A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
Hans Joachim Wagner, Catherine M. Bollard, Stéphane Vigouroux, M. Helen Huls, Robert Anderson, H. Grant Prentice, Malcolm Brenner, Helen Heslop, Cliona M. Rooney
Dive into the research topics of 'A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells'. Together they form a unique fingerprint.